• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Dyax Corp. (DYAX)

    -NasdaqGM
    23.03 Up 0.99(4.49%) 3:59PM EDT
    Add to Portfolio
    Prev Close:22.04
    Open:22.38
    Bid:6.00 x 100
    Ask:N/A
    1y Target Est:29.63
    Beta:0.710349
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:22.03 - 23.57
    52wk Range:9.19 - 30.55
    Volume:625,162
    Avg Vol (3m):952,318
    Market Cap:3.37B
    P/E (ttm):N/A
    EPS (ttm):-0.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DYAXUp 4.49%3.37B
    BCRXUp 2.32%840.79M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.28
    Quarterly EPS Est (Sep-15) :-0.08
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-2.78

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback